Product Pathways - Chromatin Regulation / Epigenetics
LSD1 (1B2E5) Mouse mAb #4064
PhosphoSitePlus® protein, site, and accession data: LSD1
| Applications | Reactivity | Sensitivity | MW (kDa) | Isotype |
|---|---|---|---|---|
| W | H M R Mk | Endogenous | 110 | Mouse IgG1 |
Applications Key:
W=Western Blotting
Reactivity Key:
H=Human
M=Mouse
R=Rat
Mk=Monkey
Species cross-reactivity is determined by western blot. Species enclosed in parentheses are predicted to react based on 100% sequence homology.
Protocols
- 4064:
- Western Blotting
Specificity / Sensitivity
LSD1 (1B2E5) Mouse mAb detects endogenous levels of total LSD1 protein.
Source / Purification
Monoclonal antibody is produced by immunizing animals with recombinant human LSD1 protein.
Background
Lysine-specific demethylase 1 (LSD1; also known as AOF2 and BHC110) is a nuclear amine oxidase homolog that acts as a histone demethylase and transcription cofactor (1). Gene activation and repression is specifically regulated by the methylation state of distinct histone protein lysine residues. For example, methylation of histone H3 at Lys4 facilitates transcriptional activation by coordinating the recruitment of BPTF, a component of the NURF chromatin remodeling complex, and WDR5, a component of multiple histone methyltransferase complexes (2,3). In contrast, methylation of histone H3 at Lys9 facilitates transcriptional repression by recruiting HP1 (4,5). LSD1 is a component of the CoREST transcriptional co-repressor complex that also contains CoREST, CtBP, HDAC1 and HDAC2. As part of this complex, LSD1 demethylates mono-methyl and di-methyl histone H3 at Lys4 through a FAD-dependent oxidation reaction to facilitate neuronal-specific gene repression in non-neuronal cells (1,6,7). In contrast, LSD1 associates with androgen receptor in human prostate cells to demethylate mono-methyl and di-methyl histone H3 at Lys9 and facilitate androgen receptor-dependent transcriptional activation (8). Therefore, depending on gene context LSD1 can function as either a transcriptional co-repressor or co-activator. LSD1 activity is inhibited by the amine oxidase inhibitors pargyline, deprenyl, clorgyline and tranylcypromine (8).
- Shi, Y. et al. (2004) Cell 119, 941-953.
- Wysocka, J. et al. (2006) Nature 442, 86-90.
- Wysocka, J. et al. (2005) Cell 121, 859-872.
- Jacobs, S.A. and Khorasanizadeh, S. (2002) Science 295, 2080-2083.
- Nielsen, P.R. et al. (2002) Nature 416, 103-107.
- Shi, Y.J. et al. (2005) Mol. Cell 19, 857-864.
- Lee, M.G. et al. (2005) Nature 437, 432-435.
- Metzger, E. et al. (2005) Nature 437, 436-439.
Application References
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
Companion Products
- 2139 LSD1 Antibody
- 9723 Mono-Methyl-Histone H3 (Lys4) Antibody
- 9727 Tri-Methyl-Histone H3 (Lys4) Antibody
- 9715 Histone H3 Antibody
- 9717 Histone H3 (3H1) Rabbit mAb
- 2062 Histone Deacetylase 1 (HDAC1) Antibody
- 7072 Phototope®-HRP Western Blot Detection System, Anti-mouse IgG, HRP-linked Antibody
- 7076 Anti-mouse IgG, HRP-linked Antibody
- 7720 Prestained Protein Marker, Broad Range (Premixed Format)
- 7727 Biotinylated Protein Ladder Detection Pack
- 7003 20X LumiGLO® Reagent and 20X Peroxide
For Research Use Only. Not For Use In Diagnostic Procedures.